FDA Neonatology Strategic Plan Should Focus On Commonly Used NICU Drugs
Executive Summary
In its first meeting, the neonatology subcommittee of FDA’s Pediatric Advisory Committee discusses challenges to studying therapeutics in infants during their first month of life and strategies for getting more neonatal-specific information about commonly used drugs into labeling.